EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA)
Clinical trials for EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA) explained in plain language.
Never miss a new study
Get alerted when new EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA) trials appear
Sign up with your email to follow new studies for EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with rare blood and vessel diseases
Disease control Recruiting nowThis study is testing a drug called benralizumab in children aged 6 to 18 with rare diseases where high levels of a specific white blood cell (eosinophil) cause inflammation and damage. The main goals are to see if the drug is safe, how it behaves in the body, and if it can help …
Matched conditions: EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA)
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC
-
Pregnant with vasculitis? researchers want to hear your story
Knowledge-focused Recruiting nowThis study aims to understand how different types of vasculitis affect pregnancy experiences and outcomes. Researchers are inviting pregnant women with various vasculitis conditions to complete online surveys during their second trimester, third trimester, and after delivery. The…
Matched conditions: EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA)
Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:10 UTC
-
Scientists map skin clues in mysterious blood vessel diseases
Knowledge-focused Recruiting nowThis study aims to learn more about how different types of vasculitis affect the skin. Researchers will collect small skin samples (biopsies) from people who have active skin lesions caused by their vasculitis. By analyzing these samples, they hope to better describe and understa…
Matched conditions: EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA)
Sponsor: Peter Merkel • Aim: Knowledge-focused
Last updated Mar 11, 2026 14:54 UTC